Please login to the form below

Not currently logged in
Email:
Password:

rheumatology

This page shows the latest rheumatology news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown

Novartis’ Cosentyx takes on Humira and biosimilar in phase III showdown

The EXCEED and SURPASS head-to-head trials are addressing important clinical questions solving residual uncertainty for patients with PsA and AS," commented Dr Robert Landewé, professor of Rheumatology in the ... Amsterdam Rheumatology and Clinical

Latest news

More from news
Approximately 1 fully matching, plus 78 partially matching documents found.

Latest Intelligence

  • Opening up innovation Opening up innovation

    We are trying to build a holistic portfolio. The first wave will be rheumatology. ... Prior to GSK, which he joined to lead the immuno-inflammation therapy unit, Paul-Peter worked in academia as a professor of medicine, in particular clinical immunology

  • Case study: Immunology education Case study: Immunology education

    Challenge. There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic

  • Case study: Immunology education Case study: Immunology education

    Challenge. There are immunological links between immune-mediated inflammatory diseases (IMIDs) in dermatology, gastroenterology and rheumatology, with patients often presenting with multiple conditions. ... Setting up a virtual biologics clinic

  • Pharma deals during April 2014 Pharma deals during April 2014

    associated with nephrotic syndrome, certain rheumatology-related conditions, and infantile spasms.

  • Pharma deals during February 2014 Pharma deals during February 2014

    Questor and Retrophin are is now in litigation over two synthetic versions of Acthar (ACTH), a corticotropin with 19 indications, many in rare diseases including infantile spasms, MS, nephrology, and rheumatology.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Creativity in a complex landscape: a pharma perspective

    Mohamed: We have multiple therapy areas in immunology – dermatology, gastroenterology, and rheumatology – and I primarily work with gastroenterology.

  • Our nursing heroes

    Going above and beyond. Carron Congreve, a rheumatology nurse at King’ s College Hospital NHS Foundation Trust, got in touch to tell us how the actions of one of our nurses

  • The Biosimilar Challenge

    In fact, recent self-funded work, showed that 89% of UK payers now positively endorse the use of biosimilars across a range of therapy areas – especially in rheumatology. ... The pressure is now on to undertake the same in rheumatology, dermatology and

  • Event: EULAR Annual European Congress of Rheumatology 2016

    Event: EULAR Annual European Congress of Rheumatology 2016. We are delighted to be attending the EULAR Annual European Congress of Rheumatology in June.

  • EULAR Annual European Congress of Rheumatology 2017

    EULAR Annual European Congress of Rheumatology 2017. Join us at EULAR Congress 2017 in Madrid, 14-17 June. ... We are delighted to be attending and presenting at this year’ s EULAR Annual European Congress of Rheumatology in June.

More from PMHub
Approximately 2 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics